Crystal structure of 3-fluoro-9-methoxy-4b,5,14, 15-tetrahydro-6H-isoquinolino [2′,1′:1,6]pyrazino [2,3-b]quinoxaline, C 19 H Abstract C 19 H17FN4O, orthorhombic, Pbca (no. 61), a = 7.0607(2) Å, b = 18.4459(5) Å, c = 23.8955(7) Å, V = 3112.17(15) Å 3 , Z = 8, Rgt(F) = 0.0543, wR ref (F 2 ) = 0.1540, T = 100(2) K.
Experimental details
The structure was solved with the SHELXL program using Olex2 [2, 3] . All hydrogen atoms were placed in the calculated positions.
Comment
Quinoxaline and its derivatives exhibit diverse biological activities, such as anticancer, antibacterial, antiviral, anti-inflammatory [4] [5] [6] . Tetrazanbigen (TNBG) was a creatively designed and synthesized leading compound bearing the quinoxaline core and showing anticancer activity [7] . Recently, a series of TNBG monosubstituted derivatives were developed with better physical properties and biological effect compared to TNBG [8] . The title compound is a disubstituted TNBG derivative, which was synthesized from (7-fluoro-1,2,3,4-tetrahydroisoquinolin-1-yl)methanamine [9] and 2,3-dichloro-6-methoxyquinoxaline [10] . It showed excellent anticancer activities against hepatoma cells, colon cancer cells and lung cancer cells in vitro, which can be deduced that the introduction of an electron-withdraw fluorine group and an electron-donating methoxy group at position C-3 and position C-9 of TNBG (see the figure) could improve their anticancer activities. All bond lengths and angles are in the normal ranges [11] . In conclusion the title compound is a potential antitumor agent, which can be used for further development.
